Drugs / AdVince
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02749331 | Mar 2016 → Aug 2025 overdue | neuroendocrine neoplasm | Uppsala University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AdVince | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02749331 ↗ |
| Route | Other | “Virus solution for infusion in intrahepatic artery” NCT02749331 ↗ |